ClearanceBrief
Recall Z-1694-2008 ยท IZQ Injector, Contrast Medium, Automatic

Mallinckrodt Inc

The OptiVantage DH Injection System is a contrast delivery system and is designed to inject radiopaque contrast media into a patient's vascular system to obtain diagnostic images when used with computed tomography equipment. The J-Bow component is used to connect the powerhead to a suspension system.

DateAug 15, 2008 (initiated Apr 7, 2008)
StatusTerminated
ReasonScrews can begin to loosen and shear off to the point of the J-Bow falling from the suspension system. This may cause injury to patients or hospital staff.
Root causeComponent design/selection
ActionOn April 18, 2008, Mallincrodt Inc. issued an Urgent Device Correction letter informing customers to check their inventory, and determine if they have any defective system units. If they observe any loose screws, sheared screws and/or elongated opening(s) around the screws, they are to immediately take the system out of service and contact the firm's service representative. Covidien's customers were all asked to inspect their inventories and to complete an 'Effectiveness Check Return Form' whether or not the product is defective. However, only those system units observed to have loose scr
Quantity783 Units
DistributionProduct is distributed in the US throughout the following states: AL, AR, AZ, CA, CO ,CT, DC, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OR, PA, RI, SC, SD, TN, TX, VA, WA, WI, and WV.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K063503OPTIVANTAGE DH INJECTOR SYSTEM WITH ENHANCED COMMUNICATION
Mallinckrodt Inc., Liebel-Flarsheim Business, Apr 27, 2007